- Home
- SGBX vs INM Comparison
SGBX vs INM Comparison
Compare SGBX & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGBX
- INM
- Stock Information
- Founded
- SGBX 2007
- INM 1981
- Country
- SGBX United States
- INM Canada
- Employees
- SGBX N/A
- INM N/A
- Industry
- SGBX RETAIL: Building Materials
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- SGBX Consumer Discretionary
- INM Health Care
- Exchange
- SGBX Nasdaq
- INM Nasdaq
- Market Cap
- SGBX 2.7M
- INM 3.2M
- IPO Year
- SGBX 2017
- INM N/A
- Fundamental
- Price
- SGBX $0.81
- INM $2.87
- Analyst Decision
- SGBX
- INM
- Analyst Count
- SGBX 0
- INM 0
- Target Price
- SGBX N/A
- INM N/A
- AVG Volume (30 Days)
- SGBX 11.2M
- INM 4.1M
- Earning Date
- SGBX 06-17-2025
- INM 05-12-2025
- Dividend Yield
- SGBX N/A
- INM N/A
- EPS Growth
- SGBX N/A
- INM N/A
- EPS
- SGBX N/A
- INM N/A
- Revenue
- SGBX $4,976,618.00
- INM $4,920,990.00
- Revenue This Year
- SGBX $1,628.82
- INM N/A
- Revenue Next Year
- SGBX N/A
- INM N/A
- P/E Ratio
- SGBX N/A
- INM N/A
- Revenue Growth
- SGBX N/A
- INM N/A
- 52 Week Low
- SGBX $0.30
- INM $1.72
- 52 Week High
- SGBX $3.75
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- SGBX 51.99
- INM 50.24
- Support Level
- SGBX $0.40
- INM $2.74
- Resistance Level
- SGBX $1.50
- INM $3.45
- Average True Range (ATR)
- SGBX 0.23
- INM 0.70
- MACD
- SGBX 0.02
- INM 0.03
- Stochastic Oscillator
- SGBX 37.04
- INM 9.40
About SGBX Safe & Green Holdings Corp.
Safe & Green Holdings Corp is a modular solutions company. The company currently provides modules made out of both code-engineered cargo shipping containers and wood for use as both permanent or temporary structures for residential housing use and commercial use, including for health care facilities. It operates in four segments: construction services; medical; real estate development; and environmental. The company generates the majority of its revenue from the Construction segment includes the company's manufacturing unit SG ECHO and other modules projects.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.